Regulation of the novel senescence pathway by SKP2 E3 ligase

Guocan Wang, Yuan Gao, Li Chen, Ying-Jan Wang, Hui Kuan Lin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cellular senescence, a stress response triggered by multiple stimuli, results in a form of irreversible cell cycle arrest that can serve as a critical barrier for cancer development. Various studies have demonstrated the critical role of ARF/p53 pathways in the induction of cellular senescence by activation of oncogenic pathways through overexpression of oncogenes, such as Ras, or by inactivation of tumor suppressor genes, such as PTEN. Recent studies also uncover novel ARF/p53-independent cellular senescence pathways in restricting tumorigenesis. Given that ARF/p53 pathways play an essential role in tumor suppression and are often inactivated in human cancers through defi ciency or mutations of ARF or p53, better understanding of these pathways governing the induction of senescence in human cancer will pave the ways for developing effective pro-senescence therapies. Thus, it’s important to screen current available drugs that stabilize p53 expression for the ability totarget possibility that these Arf-p53 dependent pathways or by developing novel inhibitors to target the Arf- p53 independent pathways.

Original languageEnglish
Title of host publicationTumor Dormancy, Quiescence, and Senescence, Volume 2
Subtitle of host publicationAging, Cancer, and Noncancer Pathologies
PublisherSpringer Netherlands
Pages33-43
Number of pages11
ISBN (Electronic)9789400777262
ISBN (Print)9789400777255
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Ubiquitin-Protein Ligases
ligases
Tumors
Cell Aging
neoplasms
Neoplasms
Genes
Chemical activation
Cells
tumor suppressor genes
oncogenes
Cell Cycle Checkpoints
Tumor Suppressor Genes
Oncogenes
Pharmaceutical Preparations
carcinogenesis
stress response
inactivation
Carcinogenesis
mutation

All Science Journal Classification (ASJC) codes

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Wang, G., Gao, Y., Chen, L., Wang, Y-J., & Lin, H. K. (2014). Regulation of the novel senescence pathway by SKP2 E3 ligase. In Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies (pp. 33-43). Springer Netherlands. https://doi.org/10.1007/978-94-007-7726-2_4
Wang, Guocan ; Gao, Yuan ; Chen, Li ; Wang, Ying-Jan ; Lin, Hui Kuan. / Regulation of the novel senescence pathway by SKP2 E3 ligase. Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies. Springer Netherlands, 2014. pp. 33-43
@inbook{26ca4b02000f4641be4758257b26ef50,
title = "Regulation of the novel senescence pathway by SKP2 E3 ligase",
abstract = "Cellular senescence, a stress response triggered by multiple stimuli, results in a form of irreversible cell cycle arrest that can serve as a critical barrier for cancer development. Various studies have demonstrated the critical role of ARF/p53 pathways in the induction of cellular senescence by activation of oncogenic pathways through overexpression of oncogenes, such as Ras, or by inactivation of tumor suppressor genes, such as PTEN. Recent studies also uncover novel ARF/p53-independent cellular senescence pathways in restricting tumorigenesis. Given that ARF/p53 pathways play an essential role in tumor suppression and are often inactivated in human cancers through defi ciency or mutations of ARF or p53, better understanding of these pathways governing the induction of senescence in human cancer will pave the ways for developing effective pro-senescence therapies. Thus, it’s important to screen current available drugs that stabilize p53 expression for the ability totarget possibility that these Arf-p53 dependent pathways or by developing novel inhibitors to target the Arf- p53 independent pathways.",
author = "Guocan Wang and Yuan Gao and Li Chen and Ying-Jan Wang and Lin, {Hui Kuan}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-94-007-7726-2_4",
language = "English",
isbn = "9789400777255",
pages = "33--43",
booktitle = "Tumor Dormancy, Quiescence, and Senescence, Volume 2",
publisher = "Springer Netherlands",
address = "Netherlands",

}

Wang, G, Gao, Y, Chen, L, Wang, Y-J & Lin, HK 2014, Regulation of the novel senescence pathway by SKP2 E3 ligase. in Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies. Springer Netherlands, pp. 33-43. https://doi.org/10.1007/978-94-007-7726-2_4

Regulation of the novel senescence pathway by SKP2 E3 ligase. / Wang, Guocan; Gao, Yuan; Chen, Li; Wang, Ying-Jan; Lin, Hui Kuan.

Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies. Springer Netherlands, 2014. p. 33-43.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Regulation of the novel senescence pathway by SKP2 E3 ligase

AU - Wang, Guocan

AU - Gao, Yuan

AU - Chen, Li

AU - Wang, Ying-Jan

AU - Lin, Hui Kuan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cellular senescence, a stress response triggered by multiple stimuli, results in a form of irreversible cell cycle arrest that can serve as a critical barrier for cancer development. Various studies have demonstrated the critical role of ARF/p53 pathways in the induction of cellular senescence by activation of oncogenic pathways through overexpression of oncogenes, such as Ras, or by inactivation of tumor suppressor genes, such as PTEN. Recent studies also uncover novel ARF/p53-independent cellular senescence pathways in restricting tumorigenesis. Given that ARF/p53 pathways play an essential role in tumor suppression and are often inactivated in human cancers through defi ciency or mutations of ARF or p53, better understanding of these pathways governing the induction of senescence in human cancer will pave the ways for developing effective pro-senescence therapies. Thus, it’s important to screen current available drugs that stabilize p53 expression for the ability totarget possibility that these Arf-p53 dependent pathways or by developing novel inhibitors to target the Arf- p53 independent pathways.

AB - Cellular senescence, a stress response triggered by multiple stimuli, results in a form of irreversible cell cycle arrest that can serve as a critical barrier for cancer development. Various studies have demonstrated the critical role of ARF/p53 pathways in the induction of cellular senescence by activation of oncogenic pathways through overexpression of oncogenes, such as Ras, or by inactivation of tumor suppressor genes, such as PTEN. Recent studies also uncover novel ARF/p53-independent cellular senescence pathways in restricting tumorigenesis. Given that ARF/p53 pathways play an essential role in tumor suppression and are often inactivated in human cancers through defi ciency or mutations of ARF or p53, better understanding of these pathways governing the induction of senescence in human cancer will pave the ways for developing effective pro-senescence therapies. Thus, it’s important to screen current available drugs that stabilize p53 expression for the ability totarget possibility that these Arf-p53 dependent pathways or by developing novel inhibitors to target the Arf- p53 independent pathways.

UR - http://www.scopus.com/inward/record.url?scp=85031400380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031400380&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-7726-2_4

DO - 10.1007/978-94-007-7726-2_4

M3 - Chapter

AN - SCOPUS:85031400380

SN - 9789400777255

SP - 33

EP - 43

BT - Tumor Dormancy, Quiescence, and Senescence, Volume 2

PB - Springer Netherlands

ER -

Wang G, Gao Y, Chen L, Wang Y-J, Lin HK. Regulation of the novel senescence pathway by SKP2 E3 ligase. In Tumor Dormancy, Quiescence, and Senescence, Volume 2: Aging, Cancer, and Noncancer Pathologies. Springer Netherlands. 2014. p. 33-43 https://doi.org/10.1007/978-94-007-7726-2_4